GLP-1 Dosing Safety and How Patients Can Avoid Mistakes
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications prescribed for managing type 2 diabetes and, increasingly, for weight loss. These drugs, which include well-known brands like Ozempic, Mounjaro, Zepbound, and Wegovy, represent a significant advancement in treatment. However, their growing popularity has been accompanied by a sharp rise in dosing errors and safety concerns. Understanding GLP-1 […]
Combined Therapies for T2D Show Improved Cardiac Health
For many years, managing type 2 diabetes (T2D) felt like a single-minded pursuit: get the blood sugar down. While crucial, this approach overlooked a more dangerous threat. People with type 2 diabetes are far more likely to experience serious cardiovascular problems, like heart attacks and strokes. The focus is now shifting towards a more comprehensive […]
GLP-1 Risks Explained Simply
You’ve probably seen headlines questioning the safety of GLP-1 medicines – the cornerstone of the wave of the latest drugs that have revolutionized many areas of healthcare, primarily in control of type 2 diabetes and the promotion of weight loss. Some of those headlines feel urgent. Others feel contradictory. One day these medications are described […]
The Hidden Effects of GLP-1 on Women
Until recently most of the talk about the new wave of medications based on GLP-1, such as Wegovy and Zepbound, centered on their positive results. They have demonstrated effectiveness in promoting weight loss in overweight and obese teenagers and adults in the general population. But there’s another side that’s getting the attention of women in […]
Study shows that early use of tirzepatide for diabetes yields cardiac benefits
Early use of tirzepatide appears to improve blood sugar, weight, and several heart-related risk markers in people with recently diagnosed type 2 diabetes. Interim findings from the SURPASS-EARLY trial conducted by Eli Lilly showed that patients treated within four years of diagnosis achieved stronger glycemic control, greater weight loss, and broader metabolic improvements than those receiving […]
Is Rybelsus the same as semaglutide?
There has been a tidal wave of interest in the new “wonder drugs” that are based on chemicals called glucagon-like peptide-1 receptor agonists (GLP-1RA), which have revolutionized treatments of a wide range of potentially serious diseases. Many people are now familiar with the common terms associated with these new treatments, such as Ozempic, Mounjaro, semaglutide […]
GLP-1 Medications and Aging: Benefits and Risks for Older Adults
GLP-1 medications like Ozempic and Mounjaro are gaining popularity among older adults not only for managing diabetes but also for their potential anti-aging effects. But alongside the benefits, there are real risks, especially for those over 65. Understanding both sides is key to making informed decisions that support healthy aging. GLP-1 drugs revolutionized the world […]
Common GLP-1 Side Effects Made Simple
Drugs like Ozempic, Wegovy, Zepbound, and Mounjaro have changed the way doctors manage type 2 diabetes and obesity. These medications, called GLP-1 receptor agonists, help the body produce more insulin after meals, slow down digestion, and reduce appetite. The results can be dramatic, including weight loss, improved blood sugar control, and a reduced risk of heart disease. But there’s […]
Wegovy is Being Tested to Treat Severe Fatty Liver Disease
Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly called non-alcoholic fatty liver disease (NASH), affects nearly one-third of the US population (over 100 million people). Obesity is thought to be the most common cause. In some cases, MASLD can develop into a more serious condition called metabolic dysfunction-associated steatohepatitis (MASH). Both conditions develop when the liver […]
Can GLP-1s Help Prevent Glaucoma?
A new study by ophthalmologists suggests that drugs based on GLP-1 receptor agonists (GLP-1RAs), like Wegovy, Mounjaro, Saxenda, Rybelsus, and Ozempic, which were originally designed to control blood sugar levels in people with type 2 diabetes, may also protect against a number of eye conditions. Research into the use of GLP-1 drugs for glaucoma found […]
